These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 1828128)

  • 1. Is compounded nasal spray safe?
    Dommisse CS
    Am Pharm; 1991 Apr; NS31(4):7. PubMed ID: 1828128
    [No Abstract]   [Full Text] [Related]  

  • 2. Supraventricular tachycardia caused by nebulised ipratropium bromide.
    O'Driscoll BR
    Thorax; 1989 Apr; 44(4):312. PubMed ID: 2527421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers.
    Corrigan DO; Corrigan OI; Healy AM
    Int J Pharm; 2006 Sep; 322(1-2):22-30. PubMed ID: 16815654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unilateral fixed dilated pupil in an infant after inhalation of nebulized ipratropium bromide.
    Woelfle J; Zielen S; Lentze MJ
    J Pediatr; 2000 Mar; 136(3):423-4. PubMed ID: 10700712
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemorrhagic bullae with nebulised ipratropium bromide.
    Saravanan V; Bankar RN; Kumar S; Williams JG
    J Postgrad Med; 2006; 52(3):235-6. PubMed ID: 16855336
    [No Abstract]   [Full Text] [Related]  

  • 6. Deposition pattern of nasal sprays in man.
    Newman SP; Morén F; Clarke SW
    Rhinology; 1988 Jun; 26(2):111-20. PubMed ID: 3175455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal ipratropium in the treatment of vasomotor rhinitis.
    Jokinen K; Sipilä P
    Rhinology; 1983 Dec; 21(4):341-5. PubMed ID: 6229864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute pupil asymmetry in a 6-month-old boy. Diagnosis: pharmacologic anisocoria.
    Osorio MJ; Zuckerbraun NS; Painter M
    Pediatr Ann; 2009 Nov; 38(11):622-4, 627. PubMed ID: 19968207
    [No Abstract]   [Full Text] [Related]  

  • 9. A benign cause for a unilateral dilated pupil in a critical care patient.
    Krovvidi HP; Thillaivasan A
    Eur J Anaesthesiol; 2008 Aug; 25(8):692-3. PubMed ID: 18339219
    [No Abstract]   [Full Text] [Related]  

  • 10. Ipratropium bromide nasal spray.
    Bandouvakis J
    Med J Aust; 1993 May; 158(10):718-9. PubMed ID: 8487698
    [No Abstract]   [Full Text] [Related]  

  • 11. Investigation of the effects of intranasal botulinum toxin type A and ipratropium bromide nasal spray on nasal hypersecretion in idiopathic rhinitis without eosinophilia.
    Sapci T; Yazici S; Evcimik MF; Bozkurt Z; Karavus A; Ugurlu B; Ozkurt E
    Rhinology; 2008 Mar; 46(1):45-51. PubMed ID: 18444492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dihydroergotamine as a nasal spray in the therapy of migraine attacks. Efficacy and tolerance].
    Jenzer G; Bremgartner MF
    Schweiz Rundsch Med Prax; 1990 Aug; 79(31-32):914-7. PubMed ID: 2203127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between the effect of ipratropium bromide as a pressurized aerosol and as an aqueous pump spray on methacholine-induced rhinorrhoea.
    Borum S; Becker B; Mygind N; Borum P
    Rhinology; 1996 Dec; 34(4):198-200. PubMed ID: 9050095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new method of drug application to the nasal passage.
    Mackenzie I
    Anaesthesia; 1998 Mar; 53(3):309-10. PubMed ID: 9613282
    [No Abstract]   [Full Text] [Related]  

  • 15. [Asynchronous double-sided angle-closure glaucoma--a condition in an ipratropium/terbutaline treated patient under artificial ventilation].
    Rasmussen H; Berger A
    Ugeskr Laeger; 1994 Nov; 156(48):7235-6. PubMed ID: 7817438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dry powder ipratropium bromide is as safe and effective as metered-dose inhaler formulation: a cumulative dose-response study in chronic obstructive pulmonary disease patients.
    Cuvelier A; Muir JF; Benhamou D; Weitzenblum E; Zuck P; Delacenserie R; Taytard A; Iacono P
    Respir Care; 2002 Feb; 47(2):159-66. PubMed ID: 11812272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal airway resistance after decongestion with a nasal spray or a bellows device.
    Jessen M; Ivarsson A; Malm L
    Rhinology; 1996 Mar; 34(1):28-31. PubMed ID: 8739865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated Stability Assessment of Extemporaneously Compounded Amiloride Nasal Spray.
    Sayre CL; Renninger B; Reaves-Mckee T; Imhoff A; Gali C; Thomas C; Patel N; Battaglia M; Davies S; Yellepeddi VK
    Int J Pharm Compd; 2024; 28(3):246-248. PubMed ID: 38768504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New ipratropium formulation to decrease nebulization time.
    Majoral C; Vecellio L; Grimbert D; de Monte M; le Guellec C; Ingremeau V; Minois C; Cordeau E; Paintaud G; Steinberg A; Diot P
    Respir Med; 2007 Feb; 101(2):237-45. PubMed ID: 16854578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latest advances in nasal drug-delivery technology.
    Bommer R
    Med Device Technol; 1999 May; 10(4):22-8. PubMed ID: 10539106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.